Home

Palisade Bio, Inc. - Common Stock (PALI)

0.7010
-0.0090 (-1.27%)

Palisade Bio Inc is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs in the field of gastrointestinal health

The company specializes in the advancement of its proprietary drug candidates aimed at improving patient outcomes, particularly in surgery-related settings and conditions affecting the digestive system. By leveraging its expertise in drug formulation and delivery, Palisade Bio seeks to enhance the safety and effectiveness of treatments, ultimately striving to enhance the quality of life for patients dealing with complex gastrointestinal disorders.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Palisade Bio, Inc. - Common Stock publicly traded?
Yes, Palisade Bio, Inc. - Common Stock is publicly traded.
What exchange does Palisade Bio, Inc. - Common Stock trade on?
Palisade Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Palisade Bio, Inc. - Common Stock?
The ticker symbol for Palisade Bio, Inc. - Common Stock is PALI on the Nasdaq Stock Market
What is the current price of Palisade Bio, Inc. - Common Stock?
The current price of Palisade Bio, Inc. - Common Stock is 0.7010
When was Palisade Bio, Inc. - Common Stock last traded?
The last trade of Palisade Bio, Inc. - Common Stock was at 3:59 pm EDT on March 24th, 2025